-
Recognized Throughout the Cancer Advocacy World for His Red Toque, Angus Pratt Brought Lung Cancer to the Fore in Many Arenas
A real-world example of the progress that has been made in lung cancer care, ILCN editorial group member and contributor Angus Pratt survived more than seven years after his lung cancer diagnosis.
More Recent News
-
IASLC Recommendations Define Core Standards for Molecular Tumor Boards
Lead author, Dr. Mihaela Aldea, discusses how the IASLC’s recently published consensus statement could strengthen new and established molecular tumor boards.
-
Atezolizumab Improves PFS, but Not OS, When Added to Chemotherapy in Older Patients With Advanced NSCLC
Dr. Céline Mascaux said the addition of atezolizumab significantly improved all secondary endpoints independent of PD-L1 expression; however, it was also associated with higher toxicity.